{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:17:05Z","timestamp":1783487825698,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fondo de Investigaciones Sanitarias, Gobierno de Espa\u00f1a","award":["PI17\/001885"],"award-info":[{"award-number":["PI17\/001885"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00259-018-4257-z","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T21:55:43Z","timestamp":1547070943000},"page":"1111-1116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"given":"Frederic","family":"Sampedro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Mart\u00ednez-Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Perez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Horta-Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Alfonso","family":"Lopez-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valle","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Fern\u00e1ndez-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Gomez-Anson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Carri\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"4257_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ. Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10:83\u201398.","journal-title":"Lancet Neurol"},{"key":"4257_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.nbd.2010.07.014","volume":"40","author":"PC Nopoulos","year":"2010","unstructured":"Nopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR, et al. Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis. 2010;40:544\u201354.","journal-title":"Neurobiol Dis"},{"key":"4257_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/B978-0-12-801893-4.00020-1","volume":"144","author":"RI Scahill","year":"2017","unstructured":"Scahill RI, Andre R, Tabrizi SJ, Aylward EH. Structural imaging in premanifest and manifest Huntington disease. Handb Clin Neurol. 2017;144:247\u201361.","journal-title":"Handb Clin Neurol"},{"key":"4257_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, et al. Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009;8:791\u2013801.","journal-title":"Lancet Neurol"},{"key":"4257_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4172\/Neuropsychiatry.1000377","volume":"08","author":"T Iwamoto","year":"2018","unstructured":"Iwamoto T, Utsumi K, Kobayashi S, Yasumura S, Hatakeyama S, Hayashi A, et al. Effect of memantine on brain metabolic activity and perfusion in drug-na\u00efve moderate Alzheimer\u2019s disease patients. Neuropsychiatry. 2018;08:546\u201354.","journal-title":"Neuropsychiatry"},{"key":"4257_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/JGP.0b013e31818cd3a4","volume":"16","author":"GW Small","year":"2008","unstructured":"Small GW, Siddarth P, Silverman DHS, Ercoli LM, Miller KJ, Lavretsky H, et al. Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. Am J Geriatr Psychiatry. 2008;16:999\u20131009.","journal-title":"Am J Geriatr Psychiatry"},{"key":"4257_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1176\/jnp.23.2.jnp206","volume":"23","author":"LE Hjermind","year":"2011","unstructured":"Hjermind LE, Law I, J\u00f8nch A, Stokholm J, Nielsen JE. Huntington\u2019s disease: effect of memantine on FDG-PET brain metabolism? J Neuropsychiatr Clin Neurosci. 2011;23:206\u201310.","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"4257_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00259-016-3324-6","volume":"43","author":"G Pagano","year":"2016","unstructured":"Pagano G, Niccolini F, Politis M. Current status of PET imaging in Huntington\u2019s disease. Eur J Nucl Med Mol Imaging. 2016;43:1171\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4257_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","volume":"132","author":"DN Greve","year":"2016","unstructured":"Greve DN, Salat DH, Bowen SL, Izquierdo-Garcia D, Schultz AP, Catana C, et al. Different partial volume correction methods lead to different conclusions: an (18)F-FDG-PET study of aging. NeuroImage. 2016;132:334\u201343.","journal-title":"NeuroImage"},{"key":"4257_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","volume":"92","author":"DN Greve","year":"2014","unstructured":"Greve DN, Svarer C, Fisher PM, Feng L, Hansen AE, Baare W, et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. NeuroImage. 2014;92:225\u201336.","journal-title":"NeuroImage"},{"key":"4257_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.02.008","volume":"25","author":"S Martinez-Horta","year":"2016","unstructured":"Martinez-Horta S, Perez-Perez J, van Duijn E, Fernandez-Bobadilla R, Carceller M, Pagonabarraga J, et al. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington\u2019s disease. Parkinsonism Relat Disord. 2016;25:58\u201364.","journal-title":"Parkinsonism Relat Disord"},{"key":"4257_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.genhosppsych.2007.11.005","volume":"30","author":"EM Kingma","year":"2008","unstructured":"Kingma EM, van Duijn E, Timman R, van der Mast RC, Roos RAC. Behavioural problems in Huntington\u2019s disease using the problem behaviours assessment. Gen Hosp Psychiatry. 2008;30:155\u201361.","journal-title":"Gen Hosp Psychiatry"},{"key":"4257_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/mds.27395","volume":"33","author":"S Mart\u00ednez-Horta","year":"2018","unstructured":"Mart\u00ednez-Horta S, Perez-Perez J, Sampedro F, Pagonabarraga J, Horta-Barba A, Carceller-Sindreu M, et al. Structural and metabolic brain correlates of apathy in Huntington\u2019s disease. Mov Disord. 2018;33:1151\u20139.","journal-title":"Mov Disord"},{"key":"4257_CR14","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","volume":"36","author":"A Varrone","year":"2009","unstructured":"Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, N\u00e5gren K, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2103\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4257_CR15","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000;97:11050\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4257_CR16","doi-asserted-by":"crossref","unstructured":"Lopez-Mora DA, et al. Selection of reference regions to model neurodegeneration in Huntington\u2019s disease by FDG-PET\/CT using imaging and clinical parameters. Clin Nucl Med. 2018;44(1):e1\u2013e5.","DOI":"10.1097\/RLU.0000000000002329"},{"key":"4257_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1017\/S1355617716000321","volume":"22","author":"I Labuschagne","year":"2016","unstructured":"Labuschagne I, Cassidy AM, Scahill RI, Johnson EB, Rees E, O\u2019Regan A, et al. Visuospatial processing deficits linked to posterior brain regions in premanifest and early stage Huntington\u2019s disease. J Int Neuropsychol Soc. 2016;22:595\u2013608.","journal-title":"J Int Neuropsychol Soc"},{"key":"4257_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neuropsychologia.2015.10.033","volume":"79","author":"EB Johnson","year":"2015","unstructured":"Johnson EB, Rees EM, Labuschagne I, Durr A, Leavitt BR, Roos RAC, et al. The impact of occipital lobe cortical thickness on cognitive task performance: an investigation in Huntington\u2019s disease. Neuropsychologia. 2015;79:138\u201346.","journal-title":"Neuropsychologia"},{"key":"4257_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/BF00598956","volume":"34","author":"SE Starkstein","year":"1992","unstructured":"Starkstein SE, Brandt J, Bylsma F, Peyser C, Folstein M, Folstein SE. Neuropsychological correlates of brain atrophy in Huntington\u2019s disease: a magnetic resonance imaging study. Neuroradiology. 1992;34:487\u20139.","journal-title":"Neuroradiology"},{"issue":"12","key":"4257_CR20","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1002\/hbm.24322","volume":"39","author":"EM Coppen","year":"2018","unstructured":"Coppen EM, van der Grond J, Hafkemeijer A, Barkey Wolf JJH, Roos RAC. Structural and functional changes of the visual cortex in early Huntington\u2019s disease. Hum Brain Mapp. 2018;39(12):4776\u201386.","journal-title":"Hum Brain Mapp"},{"key":"4257_CR21","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1038\/d41586-018-05179-w","volume":"557","author":"K Arney","year":"2018","unstructured":"Arney K. Improved metrics for Huntington\u2019s disease trials. Nature. 2018;557:S46\u20137.","journal-title":"Nature"},{"key":"4257_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RAC, Durr A, Leavitt B, Owen G, et al. Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol. 2012;11:42\u201353.","journal-title":"Lancet Neurol"},{"key":"4257_CR23","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00259-016-3445-y","volume":"43","author":"DA L\u00f3pez-Mora","year":"2016","unstructured":"L\u00f3pez-Mora DA, Camacho V, P\u00e9rez-P\u00e9rez J, Mart\u00ednez-Horta S, Fern\u00e1ndez A, Sampedro F, et al. Striatal hypometabolism in premanifest and manifest Huntington\u2019s disease patients. Eur J Nucl Med Mol Imaging. 2016;43:2183\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4257_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1212\/WNL.58.5.695","volume":"58","author":"HD Rosas","year":"2002","unstructured":"Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, et al. Regional and progressive thinning of the cortical ribbon in Huntington\u2019s disease. Neurology. 2002;58:695\u2013701.","journal-title":"Neurology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4257-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4257-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4257-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:11:57Z","timestamp":1578528717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4257-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4257"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4257-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"assertion":[{"value":"24 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author Frederic Sampedro declares that he has no conflict of interest. Author Saul Mart\u00ednez-Horta declares that he has no conflict of interest. Author Jesus Perez-Perez declares that he has no conflict of interest. Author Andrea Horta-Barba declares that she has no conflict of interest. Author Diego-Alfonso Lopez-Mora declares that he has no conflict of interest. Author Valle Camacho declares that she has no conflict of interest. Author Alejandro Fernandez-Leon declares that he has no conflict of interest. Author Beatriz Gomez-Anson declares that she has no conflict of interest. Author Ignasi Carri\u00f3 declares that he has no conflict of interest. Author Jaime Kulisevsky declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}